Telehealth companies swoop in to offer Wegovy pill

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Katie Palmer writes: As drugmaker Novo Nordisk launched the pill version of its popular obesity medication Wegovy on Monday, it aimed to capture patients with a cash-pay discount — $149 a month for the lowest starting doses of the medication through April 15. It’s also trying to onboard new patients through an expanded roster of telehealth providers.

The drugmaker’s direct-to-consumer patient portal, NovoCare, now includes links to seven telehealth companies that can prescribe its medication. The site says the providers, including 9amHealth, eMed, Form Health, Knownwell, LifeMD, Ro, and Weight Watchers, “are recognized by Novo Nordisk for legitimate medicine sourcing and patient support,” but that the company “does not endorse these health care providers or organizations.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In